HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulation/Legislation (Health)

Set Alert for Regulation {Health}

Lithuanian Liberalization ‘Justified,’ Says Vice-Minister of Health

A rush of retailers signing up to sell OTC medicines has suggested that Lithuania's decision to liberalize its OTC market was 'justified,' according to the country's Vice-Minister of Health Kristina Garuolienės. 
Health Regulation Retail

House Maintains Momentum For OTC Monograph Reform, Senate Regard TBD

House passes, with large bipartisan support, Pandemic and All-Hazards Preparedness and Advancing Innovation Act, which includes Over-the-Counter Monograph Safety, Innovation, and Reform Act for modernizing FDA's system overseeing vast majority of OTC drugs. Provisions would allow FDA to use administrative orders, rather than notice-and-comment rulemakings, to add ingredients, dosages, delivery formats or indications to monographs, or drugs marketed without approved applications.

Legislation Consumer Regulation

Polish Consumers Finding It Harder To Access OTC Drugs

Trend of pharmacy closures in 2018 threatens Polish consumers' access to consumer health products, insists local OTC association PASMI. Over 90% of OTC sales in Poland currently go through pharmacies.
Poland OTC Drugs Regulation

Regulation

Set Alert for Regulation {Health}

Latest From Health & Regulation

FDA Has Model Drug Facts Labels For OTC Naloxone, Wants Switch Proposals

Development of the model DFLs was a first for agency, reflecting alarm over public health crisis of overdoses from opioid abuse, which reached nearly 48,000 in 2017. The project was "part of our broader commitment to addressing the opioid crisis" and should help sponsors with potential naloxone OTC switch NDAs, says Commissioner Scott Gottlieb.

Prescription To Otc Switch Regulation

Irish $1.9bn Tax Bill 'Out Of Nowhere' Perplexes Perrigo, Troubles Analysts

Perrigo appeals tax assessment Ireland levied in late December on Rx ingredient royalty rights firm gained when it became incorporated in Dublin but no longer owns, Analysts allowed President and CEO Murray Kessler. benefit of doubt he'll lead Perrigo out of prolonged slump when he joined firm in November after extensive executive experience with tobacco firms and in other consumer goods markets, but they're more circumspect about its chances of prevailing in Irish tax disagreement.

Commercial Policy & Regulation

Oral-B Enamel Repair Claim Has Second Brush With UK Advertising Authority

UK Advertising Standards Authority says despite P&G’s modification of a claim in TV ads for Oral B Gum and Enamel Repair toothpaste, visuals in the ad combined with claims suggest the product can repair enamel.

Regulation Commercial
See All

Legislation

Set Alert for Legislation {Health}

Latest From Health & Legislation

Octocrylene Now? Sunscreen Industry Under Growing Pressure As Environmental Concerns Mount

Lawmakers already are taking action to ban sales of oxybenzone- and octinoxate-containing sunscreens due to signals, however questionable, that the ingredients pose dangers to coral health. Now a new study suggests that octocrylene could be a concern as well.

Health Beauty

2018 In Review: California, Hawaii Pass Personal-Care Legislation Among 300+ State Bills Overall

On par with 2017, the Personal Care Products Council was tracking more than 300 state bills last year with potential implications for its members, including measures ultimately enacted by California and Hawaii to deter cosmetic animal testing and ban environmentally questionable sunscreens.

Legislation Health

Key West Weighing Oxybenzone/Octinoxate Sunscreen Ban Per Hawaii’s Example

The Florida island city could be the next jurisdiction to prohibit the sale of oxybenzone- and octinoxate-containing sunscreens. Industry maintains that available science does not clearly link the ingredients to coral decline, with the Personal Care Products Council asking to present before the Key West City Commission at its January meeting.

Health Beauty
See All
UsernamePublicRestriction

Register